2seventy bio, Inc.
TSVT
$3.10
$0.4516.98%
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Revenue | 184.07% | 157.43% | 144.26% | 67.82% | 6.12% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 184.07% | 157.43% | 144.26% | 67.82% | 6.12% |
| Cost of Revenue | -4.56% | -2.16% | 0.75% | 0.16% | -5.16% |
| Gross Profit | 48.81% | 45.13% | 32.65% | 16.61% | 7.46% |
| SG&A Expenses | -15.62% | -11.39% | -17.72% | -15.03% | -6.31% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -7.21% | -4.44% | -3.97% | -3.70% | -5.44% |
| Operating Income | 39.51% | 35.20% | 28.21% | 16.14% | 7.14% |
| Income Before Tax | 37.01% | 36.59% | 25.88% | 13.02% | 5.21% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 37.02% | 36.60% | 25.89% | 13.03% | 5.21% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 37.02% | 36.60% | 25.89% | 13.03% | 5.21% |
| EBIT | 39.51% | 35.20% | 28.21% | 16.14% | 7.14% |
| EBITDA | 40.15% | 35.01% | 27.75% | 15.41% | 6.71% |
| EPS Basic | 59.03% | 58.75% | 54.22% | 39.11% | 27.67% |
| Normalized Basic EPS | 63.30% | 58.78% | 54.26% | 39.07% | 27.80% |
| EPS Diluted | 59.03% | 58.75% | 54.22% | 39.11% | 27.67% |
| Normalized Diluted EPS | 63.30% | 58.78% | 54.26% | 39.07% | 27.80% |
| Average Basic Shares Outstanding | 44.44% | 52.77% | 63.39% | 51.49% | 36.49% |
| Average Diluted Shares Outstanding | 44.44% | 52.77% | 63.39% | 51.49% | 36.49% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
